Home » Topics » BioWorld Science

BioWorld Science
RSS

Pan-TRK/ROS1 dual inhibitor XZP-5955 shows brain penetration, activity against mutations

July 10, 2020

Sorrento Therapeutics presents preclinical data on STI-6129 for multiple myeloma

July 10, 2020

Phase III FIDELIO-DKD study of finerenone meets primary endpoint

July 10, 2020

Janssen Pharmaceutica and Johnson & Johnson present new HBV antivirals

July 10, 2020

Camphor Pharmaceuticals synthesizes CDK4 and/or CDK6 inhibitors

July 10, 2020

Shenzhen Targetrx Biotechnology divulges new protein kinase inhibitors

July 10, 2020

Chinese investigators identify new ER antagonists

July 10, 2020

Janpix and University of Toronto patent STAT3 and/or STAT5 inhibitors

July 10, 2020

KIFC1 as a new therapeutic target and biomarker in CRC

July 10, 2020

Novel inhibitor of CBP/p300 shows promising activity in AR-positive breast cancer

July 10, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...